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ABSTRACT: Norcoclaurine synthase (NCS) is a Pictet-
Spenglerase that catalyzes the ﬁrst key step in plant
benzylisoquinoline alkaloid metabolism, a compound
family that includes bioactive natural products such as
morphine. The enzyme has also shown great potential as a
biocatalyst for the formation of chiral isoquinolines. Here
we present new high-resolution X-ray crystallography data
describing Thalictrum f lavum NCS bound to a mechanism-
inspired ligand. The structure supports two key features of
the NCS “dopamine-ﬁrst” mechanism: the binding of
dopamine catechol to Lys-122 and the position of the
carbonyl substrate binding site at the active site entrance.
The catalytically vital residue Glu-110 occupies a
previously unobserved ligand-bound conformation that
may be catalytically signiﬁcant. The potential roles of
inhibitory binding and alternative amino acid conforma-
tions in the mechanism have also been revealed. This work
signiﬁcantly advances our understanding of the NCS
mechanism and will aid future eﬀorts to engineer the
substrate scope and catalytic properties of this useful
biocatalyst.
Norcoclaurine synthase (NCS) catalyzes the formation of(1S)-substituted tetrahydroisoquinolines via a Pictet-
Spengler reaction between a β-arylethylamine and a carbonyl-
containing compound (Figure 1a).1 The natural reaction
catalyzed by NCS involves the condensation of dopamine 1
and 4-hydroxyphenylacetaldehyde (4-HPAA) 2, forming (S)-
norcoclaurine 4 (Figure 1b).1−3 This is the ﬁrst committed step
into the plant benzylisoquinoline alkaloids (BIA), a diverse
family of bioactive natural products that includes morphine and
berberine.4
NCS has also played a key role in in vivo heterologous
reconstitutions of BIA biosynthesis,5−8 and because of its
considerable carbonyl substrate promiscuity, it has been used
for the in vitro production of alkaloids.9−18 Therefore, a
thorough understanding of the NCS mechanism will both shed
light on a key aspect of plant specialized metabolism and enable
rational enzyme engineering to improve the catalytic eﬃciency
and substrate scope of a promising biocatalyst.
Two enzyme mechanisms have been proposed, which diﬀer
most simply by the order in which the substrates bind to the
enzyme. In the “HPAA-ﬁrst” mechanism, the carbonyl substrate
binds prior to dopamine.19,20 This mechanism was inspired by
the observed binding modes of dopamine and the non-
productive aldehyde p-hydroxybenzaldehyde in structural data
from X-ray crystallography [Protein Data Bank (PDB) entry
2VQ5].19 However, this mechanism cannot account for the
carbonyl substrate promiscuity of the enzyme,9,10 nor does it
provide a residue to deprotonate the dopamine 3-OH, which
had previously been shown to be a key reaction step.21
Computational docking and mutagenesis experiments led to
the development of an alternative dopamine-ﬁrst mechanism, in
which dopamine binds deep in the active site and the carbonyl-
derived substituent is positioned at the active site entrance,
partially exposed to the solvent.10,12 The location of this
carbonyl substrate binding site can account for the enzyme
promiscuity and has been supported by amino acid
substitutions that have altered the enzyme carbonyl substrate
tolerance.12,17
The dopamine-ﬁrst mechanism (Figure 1c) involves initial
binding of dopamine 3-OH to residue K122, and binding of the
nitrogen to E110 and D141. The carbonyl substrate binds
subsequently, and iminium formation is catalyzed by Y108,
E110, and D141. Electrophilic addition is triggered by
deprotonation of 3-OH by K122, and this is followed by
deprotonation of the quinone by E110, revealing the product.
Here we provide the ﬁrst experimental structural evidence at
high resolution for the dopamine-ﬁrst mechanism. We have
crystallized Thalictrum f lavum NCS (TfNCS) and used a
nonproductive mechanism-inspired ligand to generate struc-
tures with an intermediate mimic bound, which validate key
predictions of the dopamine-ﬁrst mechanism: the binding of
dopamine 3-OH to K122 and the position of the carbonyl
substituent at the active site entrance. The structures also reveal
two distinct conformations of the mechanistically vital E110
side chain.
To minimize ﬂexible residues to promote crystallization, a
truncated TfNCS1 construct was designed, lacking 33 residues
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from the N-terminus and residues 196−210 from the C-
terminus (ΔN33C196TfNCS) (Figure S1). The truncations
did not aﬀect the enzyme activity compared to that of
Δ29TfNCS (Figure S2). The structure of ΔN33C196TfNCS
was determined in apo form at 2.00 Å resolution, with three
copies in the asymmetric unit (PDB entry 5N8Q, Table S1).
The apo monomer structures were similar to the previously
published structures of Δ19TfNCS; the Cα root-mean-square
deviation (RMSD) calculated among all possible monomer
pairs of the apo structure 5N8Q and 2VQ5 was just 0.5−0.8 Å.
The highest RMSD was found for residues G102 and E103 that
reside in a ﬂexible loop region with high B factors. Active site
residue F112 was present in all new structures as a single
rotamer, as predicted by molecular dynamics simulations.12
Attempts to observe dopamine 1 or (S)-norcoclaurine 4
bound in the active site by soaking or co-crystallization were
not successful. Instead, the binding of a reaction intermediate
mimic was investigated. The reaction mechanism is expected to
proceed via an iminium intermediate (Figure 1b,c).21 It was
hypothesized that a secondary amine would mimic the behavior
of the iminium species in the active site (Figure 1b). The mimic
was based on the iminium intermediate of the reaction between
dopamine 1 and 4-methoxyphenylacetaldehyde 3 (4-MOPAA),
producing (S)-argemexirine 5. 4-MOPAA 3 diﬀers from natural
substrate 4-HPAA 2 by only a single methyl group and is less
sensitive to oxidation. This reaction was previously demon-
strated to be catalyzed eﬃciently by both TfNCS9 and Coptis
japonica NCS2,10 equaling or exceeding the conversion of 4-
HPAA 2.
Mimic 6 was synthesized in three steps from the reported
amine 3,4-bis(benzoyloxy)dopamine via amide coupling,
reduction, and deprotection (overall three-step puriﬁed yield
of 25%). Co-crystallization of the protein and mimic 6
generated a mimic-bound structure at 1.85 Å resolution
(PDB entry 5NON, Table S1). The structures showed 6
residing in the active site, with the catechol group bound to
K122 (distance of 2.6 Å) (Figure 2a,b). The presence of this
protein−ligand interaction is unequivocal and veriﬁes a key
interaction predicted by the dopamine-ﬁrst mechanism.
Interestingly, 6 appeared to adopt two possible orientations
within the active site, one productive orientation in which 3-
OH was closest to K122 and an inhibitory orientation in which
4-OH was closest (Figure 3a,b). The proposed mechanism
requires the 3-OH to be deprotonated by K122 (Figure 1c),
which is supported by the loss of detectable product formation
when the 3-OH substitution of β-arylethylamine substrates is
absent or modiﬁed.9,10 The contribution of the orientations was
estimated by reﬁning the occupancy constrained to a total of
1.0 of the two ligand conformations in each site (Figure 3a,b).
This method showed the productive and inhibitory orientations
accounted for approximately 70 and 30% of the density,
respectively (see Figure S4 for diﬀerent interpretations of the
ligand electron density). It is unclear whether the inhibitory
orientation of the ligand is biologically relevant; the more rigid
iminium reaction intermediate may not be able to occupy such
a conformation. However, computational docking studies with
5NON suggested that dopamine alone could bind in equivalent
productive and inhibitory orientations (Figure 3c,d). The
Figure 1. NCS-catalyzed reaction. (a) General reaction catalyzed by NCS. (b) NCS reactions with 4-hydroxyphenylacetaldehyde 2 (4-HPAA) and 4-
methoxyphenylacetaldehyde (4-MOPAA) 3, and the intermediate mimic 6. (c) Outline of the proposed dopamine-ﬁrst mechanism prior to these
results.
Figure 2. Mimic bound in the active site of structure 5NON. (a)
Overall structure, solvent-excluded surface, and active site entrance.
The mimic is depicted as gray spheres. (b) The major conformation of
the mimic is shown as gray sticks. Key active site side chains and loops
are depicted. The distance between dopamine 3-OH and K122 (black
dashed line) is 2.6 Å. The protein solvent-excluded surface has been
clipped to show the active site cavity.
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productive binding mode is predicted to be only slightly more
favorable than the inhibitory mode (Table S2). The presence of
these inhibitory binding modes may reduce the catalytic
eﬃciency of the enzyme.22
The binding of ligand 6 to the protein caused changes to
amino acid side chain orientations, most signiﬁcantly to the
catalytically vital residue E110. Two distinct conformations
were apparent in the structures. The apo structure featured the
same E110 conformation as observed in previously published
structures (Figure 4a),19 while in the mimic-bound structure, a
novel ligand-bound conformation was present (Figure 4b). The
ligand-bound conformation of E110 is characterized by a H-
bond to water 201, which in turn was bound to the main chains
of V124 and M126 and the side chain of D141, all conserved
residues throughout NCSs (Figure 4b and Figure S1).23 This
mimic-bound structure conformation brings the carboxyl group
of E110 close to D141, forming a negatively charged region in
which a positively charged ligand nitrogen can bind. The
productive binding mode of dopamine generated by computa-
tional docking to the mimic-bound structure highlights the fact
that both E110 and D141 are within H-bonding distance of the
substrate nitrogen (Figure 3c).
A proposed mechanistic role of E110 is the deprotonation of
the quinone intermediate at C8a, which results in the formation
of the aromatic THIQ product (Figure 1c). Binding modes of
the quinone intermediate generated by computational docking
suggest the non-water-bound apo E110 conformation is
required for this reaction step (Figure 4c and Table S2). This
suggests that both conformations of E110 may be mechanis-
tically important but required for diﬀerent catalytic steps. Such
a role of E110 is supported by previous experiments in which
the E110D variant had no measurable activity;12 the exact side
chain length is necessary for E110 to perform its precise role.
Adjacent to D141 are the fully conserved residues Y108 and
Y139, and the partially conserved Y131 (Figure S1). These
hydrophilic residues may aid in the removal of water from the
active site at the initial condensation step (Figure 4d).
The carbonyl substrate-derived portion of the ligand is
oriented toward the active site entrance (Figure 2a). This
supports a key prediction of the dopamine-ﬁrst mechanism: the
location of the carbonyl substrate binding site near the bulk
solvent, which accounts for the substrate promiscuity of the
enzyme. The ligand interaction is slightly more constrained
than predicted by computational docking experiments; the
ligand methoxy group is bound between L72 and L76. It is
unclear how such a conformation could be adopted when
bulkier carbonyl substituents are present (e.g., citronellal12).
Ligand binding triggered subtle changes to amino acid
conformations, as judged by RMSD comparisons with the apo
structure. In subunits A and B, there appear to be changes in
the active site entrance loop (residues 76−80) both in the side
chains and in the Cα positions (Figure S5). This region is
known to inﬂuence carbonyl substrate speciﬁcity, with amino
acid substitutions shown to increase the levels of conversion
with some unnatural substrates.12,17,18 Amino acids in this loop,
with the exception of A79, are fully conserved among known
NCSs.23 There were also changes in the conformation and
increased ﬂexibility in loop 99−103 upon ligand binding
(Figure S5). Within this loop, F99 shows particular proximity
to the aldehyde substituent and, along with G102, is conserved
among NCSs.23 In all three subunits, the positions of residues
177 and 180 also appear to shift upon ligand binding. These
residue motions upon ligand binding are corroborated by
previous nuclear magnetic resonance experiments that detected
ligand-dependent chemical shift perturbations of residues 99,
100, 177, and 180.24
The cyclization step in the reaction mechanism requires C6
and the iminium carbon to come into the proximity before C−
C bond formation can occur (Figure 1c). It is possible that the
subtle amino acid movements of loops 76−80 and 99−103 are
coupled to this change in the intermediate conformation. Such
a hypothesis could account for the observation that increased
bulk in loop 76−80 (mutants A79I and A79F) improved
Figure 3. Interactions between catechol and K122. (a) Productive and
(b) inhibitory mimic binding orientations, accounting for approx-
imately 70 and 30% occupancy, respectively. The arrangement is
productive when 3-OH is bound to K122. (c) Productive and (d)
inhibitory dopamine binding orientation generated by computational
docking. Numbers show the lengths in angstroms of the dotted lines.
Figure 4. Water in the active site. Water 201 interactions in (a) apo
and (b) mimic-bound structures. (c) Quinone intermediate (light
blue) docked into the 5NON active site (residues colored beige). Apo
residues are colored gray to show proximity of E110 to C8a. Numbers
are distances in angstroms. (d) Water channel mediated by hydrophilic
active site residues. Gray sticks show the bound mimic; light blue
sticks show (S)-hemiacetal docked into the active site, highlighting the
position of the water leaving group. The protein solvent-excluded
surface has been clipped to show the active site cavity.
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conversions17 and enzyme activities (Figure S3) with certain
substrates (for the proposed mechanism, see Figure S6).
The investigation of the TfNCS structure with a
mechanistically inspired ligand has provided structural data in
support of the dopamine-ﬁrst mechanism. The two key
observations supporting this model are the interactions
between the K122 and the dopamine-derived catechol moiety,
and the orientation of the aldehyde substituent toward the
active site entrance. The study has also revealed novel features
of the NCS mechanism, including the variable conformations of
E110 and the possibility of inhibitory substrate binding modes.
Overall, this improved understanding of the enzyme structure
and mechanism will aid rational engineering approaches to
increasing the kinetic parameters and widening the substrate
scope of an important biocatalyst.
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